4534.T Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 09:15):

Stats
Dzisiejszy wolumen	13 200.00
Średni wolumen	35 740.00
Kapitalizacja rynkowa	110.04B
EPS	¥0 ( 2024-02-04 )
Następna data zysków	( ¥0 ) 2024-05-12
Last Dividend	¥40.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	37.18
ATR14	¥4.04 (0.13%)

Mochida Pharmaceutical Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Mochida Pharmaceutical Finanse

Annual	2022
Przychody:	¥103.26B
Zysk brutto:	¥55.12B (53.37 %)
EPS:	¥178.93

FY	2022
Przychody:	¥103.26B
Zysk brutto:	¥55.12B (53.37 %)
EPS:	¥178.93

FY	2022
Przychody:	¥110.18B
Zysk brutto:	¥59.55B (54.05 %)
EPS:	¥277.39

FY	2021
Przychody:	¥103.00B
Zysk brutto:	¥54.79B (53.20 %)
EPS:	¥222.29

Financial Reports:

No articles found.

Mochida Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥40.00 (N/A)	¥0 (N/A)	¥40.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Mochida Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 7.75 - good (77.51%) | Divividend Growth Potential Score: 2.27 - Decrease likely (54.55%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥9.38	2001-03-27
Last Dividend	¥40.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	46	--
Total Paid Out	¥1 333.13	--
Avg. Dividend % Per Year	0.00%	--
Score	2.96	--
Div. Sustainability Score	7.75
Div.Growth Potential Score	2.27
Div. Directional Score	5.01	--

Next Divdend (Est)
(2024-07-03)

¥0 Estimate 1.26 %

Dividend Stability

0.10 Bad

Dividend Score

2.96

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
7476.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6702.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6037.T	Ex Dividend Junior	2024-07-30	Sporadic	0.00%
4725.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
3965.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3176.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
2163.T	Ex Dividend Knight	2024-01-30	Semi-Annually	0.00%
9042.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
7932.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
7150.T	Ex Dividend Junior	2023-09-28	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0301	1.500	9.40	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0191	1.200	9.36	10.00	[0 - 0.3]
returnOnEquityTTM	0.0237	1.500	-0.848	-1.272	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	4.39	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	3.04	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.157	1.500	4.68	7.02	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	3 942.00	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	32.98	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	8.79	2.00	5.61	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.512	1.000	4.79	4.79	[0.2 - 0.8]
operatingProfitMarginTTM	0.0394	1.000	-1.212	-1.212	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.634	0.800	9.11	7.28	[0.5 - 2]
Total Score				7.75

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	37.66	1.000	6.30	0	[1 - 100]
returnOnEquityTTM	0.0237	2.50	-0.545	-1.272	[0.1 - 1.5]
freeCashFlowPerShareTTM	8.79	2.00	7.07	10.00	[0 - 30]
dividendYielPercentageTTM	2.51	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	32.98	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-1.061	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0117	1.000	-2.21	0	[0.1 - 0.5]
Total Score				2.27

Mochida Pharmaceutical

Mochida Pharmaceutical Co., Ltd. produces and sells pharmaceuticals, skincare products, and diagnostics solutions in Japan. The company provides cardiovascular, analgesic, gastrointestinal, neurological, anti-infective, antidiabetics, and anticancer products, as well as hormone and biological preparations, and biosimilars; diagnostic reagents, such as reagents for fertility/infertility and other reagents; and face and body care, hair care, and skincare products, as well as dermatology, psychiatry, obstetrics, and gynecology products. It also developing drugs for the treatment of intractable diseases. The company has collaboration agreements with Amarin Corporation plc for the development and commercialization of ethyl icosapentate products; and Gene Techno Science Co., Ltd. to develop new regenerative medicine for the treatment of digestive rare and intractable diseases, such as congenital isolated hypoganglionosis. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.